Recall
FDAHealthSeptember 4, 2025

Zydus Pharmaceuticals (USA) Inc — Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pen

⚠️ Failed Impurity/Degradation Specifications

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
September 4, 2025

U.S. Nationwide

What's affected?

Product
Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.
Lot code
E309376

Additional details

Lot E309376; Exp 11/30/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 4344 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.